We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

72 hedge funds and large institutions have $203M invested in ChemoCentryx, Inc. in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

25% more capital invested

Capital invested by funds: $163M → $203M (+$40M)

11% more funds holding

Funds holding: 6572 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

52% less call options, than puts

Call options by funds: $293K | Put options by funds: $615K

Holders
72
Holders Change
+7
Holders Change %
+10.77%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
22
Reduced
17
Closed
4
Calls
$293K
Puts
$615K
Net Calls
-$322K
Net Calls Change
-$425K
Name Holding Trade Value Shares
Change
Change in
Stake
NFA
51
Nationwide Fund Advisors
Ohio
$151K
AIG
52
American International Group
New York
$133K -$205 -29 -0.2%
Wells Fargo
53
Wells Fargo
California
$123K -$4.64K -656 -4%
Morgan Stanley
54
Morgan Stanley
New York
$118K +$10.8K +1,527 +12%
VOYA Investment Management
55
VOYA Investment Management
Georgia
$105K
PNC Financial Services Group
56
PNC Financial Services Group
Pennsylvania
$91K
PPA
57
Parametric Portfolio Associates
Washington
$88K -$1.76K -249 -2%
FIM
58
Fernwood Investment Management
Massachusetts
$81K
CG
59
Cutler Group
California
$69K +$60.8K +8,591 New
Citigroup
60
Citigroup
New York
$60K +$52K +7,354 +183,850%
Group One Trading
61
Group One Trading
Illinois
$45K +$19K +2,691 +96%
BNP Paribas Financial Markets
62
BNP Paribas Financial Markets
France
$43K -$8.62K -1,218 -19%
Barclays
63
Barclays
United Kingdom
$31K -$57.6K -8,139 -68%
UBS Group
64
UBS Group
Switzerland
$17K -$4.5K -636 -23%
BJ
65
BlackRock Japan
Japan
$17K +$15.2K +2,152 New
BlackRock
66
BlackRock
New York
$13K +$7.08K +1,000 +162%
Bank of Montreal
67
Bank of Montreal
Ontario, Canada
$12K +$10.3K +1,457 New
CSS
68
Cubist Systematic Strategies
Connecticut
$3K +$2.45K +346 New
TRCT
69
Tower Research Capital (TRC)
New York
$2K +$1.42K +200 New
Simplex Trading
70
Simplex Trading
Illinois
$1K +$1.5K +212 New
Manulife (Manufacturers Life Insurance)
71
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$152
Marshall Wace
72
Marshall Wace
United Kingdom
-$1.71M -282,713 Closed
Millennium Management
73
Millennium Management
New York
-$367K -60,718 Closed
EGA
74
Eagle Global Advisors
Texas
-$74K -12,287 Closed
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
-$9.29K -1,313 -97%

CCXI Hedge Fund Activity: Q4 2015 in Review

72 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2015, worth a combined $203M — up 25% from $163M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CCXI positions and 4 closed out — a net gain of 7 holders — while 22 added to existing stakes and 17 trimmed.

The largest buyer was Credit Suisse, adding an estimated $2.69M. The largest seller was BVF Inc, cutting an estimated $6.34M.

  • 72 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2015, up from 65 in Q3 2015.
  • Funds reported $203M of ChemoCentryx, Inc. stock for Q4 2015, up 25% quarter-over-quarter.
  • 11 funds opened new ChemoCentryx, Inc. positions in Q4 2015 and 4 closed out, a net change of +7 holders.
  • The largest ChemoCentryx, Inc. buyer in Q4 2015 was Credit Suisse, an estimated $2.69M added.
  • The largest ChemoCentryx, Inc. seller in Q4 2015 was BVF Inc, an estimated $6.34M sold.

Based on aggregated 13F filings for Q4 2015.